3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Leukemia, Myeloid, Acute
1
Interventions
Cyclophosphamide
22
fludarabine phosphate
17
Cyclosporine
15
Peripheral Blood Stem Cell Transplantation
14
Methotrexate
14
Filgrastim
14
Whole-Body Irradiation
11
Mycophenolic Acid
11
Busulfan
11
Antilymphocyte Serum
11
Radiotherapy
8
Melphalan
8
Exercise
8
Dexamethasone
8
Cytarabine
8
Asparaginase
8
venetoclax
7
blinatumomab
7
Vincristine
7
Etoposide
7
Daunorubicin
7
fludarabine
6
Methylprednisolone
6
Mercaptopurine
6
Granulocyte Colony-Stimulating Factor
6
Therapeutics
5
Psychiatric Rehabilitation
5
Prednisone
4
Immunotherapy, Adoptive
4
Cord Blood Stem Cell Transplantation
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Lymphatic Irradiation
×
Clear all
NCT06845592
2025-03-04
SHARP
University Of Perugia
Phase NA
Recruiting
51 enrolled